Marisol Soengas, Melanoma Group Leader at Spanish National Cancer Centre (CNIO), shared a post on X:
“I didn’t get a chance to ask for your permission, Professor Georgina Long, but I thought that those who couldn’t attend your presentation on INTerpath-001 at ESMO might like to see how you started your talk.
Thanks to all teams across the 157 participating centers!”
You can also read:
INTerpath-001 Trial: Personalized mRNA Cancer Vaccine in High-Risk Melanoma
